# Osage University Partners: portfolio, investments and team

> Osage University Partners is a vc firm based in United States. 93 investments on record, 3 in the last 12 months, latest Aug 2026.

Source: https://millionrounds.com/fund/osage-university-partners (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Osage University Partners

Last cheque observed Aug 2026; 93 cheques on record.

Email

Deploying now New fund $196M, Apr 2023 VC firm

Seed Series A Series B Graduate Environnement Mental Health

Follow Osage University Partners and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fosage-university-partners)

Deploying now

**100%** of best year **3** **cheques in 12 months**, 93 on record

Since the last cheque **68** days **00** hrs **00** min **00** sec

Median round **$40M** Cheque size, as they say **$5.0M – $20M** Rounds led **0 of 93** Sole investor **3 rounds** Exits **6 from the portfolio** Mostly in **United States, 97%**

Pitch Osage University Partners

## Osage University Partners highlights

- 01 3 cheques in the last 12 months
- 02 Mostly Series A and Series B: 65% of its rounds
- 03 Sole investor in 3 rounds, median $5.8M
- 04 6 exits from the portfolio

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** $5.0M – $20M as they say
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Graduate Environnement Mental Health
- **Based in:** Bala Cynwyd, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **93 appearances**

- **2026** 3 rounds
- **Aug** **[Quintessent](https://millionrounds.com/company/quintessent)** Series A · US · Ventureburn **$40M** With 12 others
- **May** **[Tessera Labs](https://millionrounds.com/company/tessera-labs)** Series A · TechStartups **$60M** With 3 others
- **Jan** **[Nocion Therapeutics](https://millionrounds.com/company/nocion-therapeutics)** Series B · US · Lumira Ventures **$23M** With 9 others
- **2025** 1 round
- **Apr** **[Atsena Therapeutics](https://millionrounds.com/company/atsena-therapeutics)** Series C · US · Hatteras Venture Partners **$150M** With 9 others
- **2021** 2 rounds
- **Sept** **[Vanqua Bio](https://millionrounds.com/company/vanqua-bio)** Series B · US · Firms' own news pages **$85M** With 8 others
- **Mar** **[Artizan Biosciences, Inc.](https://millionrounds.com/company/artizan-biosciences-inc)** Series A · US · Hatteras Venture Partners **$11M** With 4 others
- **2019** 16 rounds
- **Nov** **[PMV Pharma](https://millionrounds.com/company/pmv-pharma)** Series C · US · Prweb **$62M** With 7 others
- **Oct** **[ArsenalBio](https://millionrounds.com/company/arsenalbio)** Series A · US · FinSMEs **$85M** With 6 others
- **Oct** **[Cyteir Therapeutics](https://millionrounds.com/company/cyteir-therapeutics)** US · FinSMEs **$40M** With 5 others
- **Aug** **[Landos Biopharma](https://millionrounds.com/company/landos-biopharma)** Series B · US · FinSMEs **$60M** With 3 others
- **Aug** **[Cleave Therapeutics](https://millionrounds.com/company/cleave-therapeutics)** Series C · US · Businesswire **$12M** With 8 others
- **Jul** **[Menlo Security](https://millionrounds.com/company/menlo-security)** Series D · US · FinSMEs **$75M** With 7 others
- **Jun** **[Everactive](https://millionrounds.com/company/everactive)** US · Finance **$30M** With 4 others
- **Jun** **[Artizan Biosciences](https://millionrounds.com/company/artizan-biosciences)** Series A · US · Hatteras Venture Partners **$12M** With 7 others
- **Jun** **[SiFive](https://millionrounds.com/company/sifive)** Series D · US · FinSMEs **$65M** With 5 others
- **May** **[Algorithmia](https://millionrounds.com/company/algorithmia)** Series B · US · FinSMEs **$25M** With 5 others
- **May** **[LunaPBC](https://millionrounds.com/company/lunapbc)** US · FinSMEs **$4.6M** With 4 others
- **Apr** **[Sasuma Pharmaceuticals](https://millionrounds.com/company/sasuma-pharmaceuticals)** US · Biospace **$62M** With 9 others
- **Apr** **[Arrakis Therapeutics](https://millionrounds.com/company/arrakis-therapeutics)** Series B · US · FinSMEs **$75M** With 13 others
- **Mar** **[Hyalex Orthopaedics](https://millionrounds.com/company/hyalex-orthopaedics)** Series A · US · FinSMEs **$33M** With 3 others
- **Feb** **[Vor Biopharma](https://millionrounds.com/company/vor-biopharma)** Series A · US · FinSMEs **$42M** With 3 others
- **Feb** **[KenSci](https://millionrounds.com/company/kensci)** Series B · US · FinSMEs **$22M** With 4 others
- **2018** 9 rounds
- **Aug** **[StreetLight Data](https://millionrounds.com/company/streetlight-data)** Series C · US · FinSMEs **$10M** With 2 others
- **Jul** **[Antiva](https://millionrounds.com/company/antiva)** Series C · US · FinSMEs **$15M** With 5 others
- **Jun** **[Precision](https://millionrounds.com/company/precision)** Series B · US · FinSMEs **$110M** With 18 others
- **Jun** **[Embodied](https://millionrounds.com/company/embodied)** Series A · US · FinSMEs **$22M** With 3 others
- **May** **[Medisix](https://millionrounds.com/company/medisix)** Series A · SG · DealStreetAsia **$20M** With 2 others
- **May** **[Escient](https://millionrounds.com/company/escient)** Series A · US · FinSMEs **$40M** With 2 others
- **Apr** **[Synthorx](https://millionrounds.com/company/synthorx)** Series C · US · FinSMEs **$63M** With 4 others
- **Feb** **[CounterFlow AI](https://millionrounds.com/company/counterflow-ai)** Seed · US · FinSMEs **$2.7M** Sole investor
- **Jan** **[Ribon Therapeutics](https://millionrounds.com/company/ribon-therapeutics)** Series B · US · Marketwatch **$65M** With 7 others
- **2017** 9 rounds
- **Dec** **[Aptinyx](https://millionrounds.com/company/aptinyx)** Series B · US · FinSMEs **$70M** With 15 others
- **Dec** **[Pionyr](https://millionrounds.com/company/pionyr)** Series B · US · FinSMEs **$62M** With 5 others
- **Dec** **[Menlo Security](https://millionrounds.com/company/menlo-security)** Series C · US · FinSMEs **$40M** With 7 others
- **Nov** **[Quantum Circuits](https://millionrounds.com/company/quantum-circuits)** Series A · US · Boston **$18M** With 3 others
- **Jun** **[Algorithmia](https://millionrounds.com/company/algorithmia)** Series A · US · TechCrunch **$11M** With 3 others
- **Mar** **[Antiva Biosciences](https://millionrounds.com/company/antiva-biosciences)** Series C · US · FinSMEs **$22M** With 4 others
- **Mar** **[Spero Therapeutics](https://millionrounds.com/company/spero-therapeutics)** Series C · US · FinSMEs **$52M** With 8 others
- **Feb** **[Arrakis Therapeutics](https://millionrounds.com/company/arrakis-therapeutics)** Series A · US · FinSMEs **$38M** With 4 others
- **Feb** **[PMV Pharmaceuticals](https://millionrounds.com/company/pmv-pharmaceuticals)** Series B · US · FinSMEs **$74M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **6 named**

CD **Claudia Dunnous** CFO i Form ADV

LP **Louis P. Berneman** Mr. Berneman is also a Managing Partner i Filing they signed

MA **Marc A. Singer** Managing Member of the General Partner i Filing they signed

MS **Matthew S. Cohen** Managing Member of the General Partner i Filing they signed

RS **Robert s. Adelson** Mr. Adelson is also a Managing Partner i Filing they signed

WS **William S. Harrington** Mr. Harrington is also a managing partner i Filing they signed

We also hold **25** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$785M** gross assets of its funds Oct 2026

**Exempt** reporting adviser venture or small private funds

- **Legal name:** OUP Management Co., LLC
- **SEC number:** CRD 312857

## What they claim to have backed

From their own portfolio page (on their website)

**0** of 3 we have independently watched raise

Investor Portal Member here

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

## Exits from the portfolio

Companies it backed that were later bought or listed **6 in all**

**[Body Labs](https://millionrounds.com/company/body-labs)** Bought by [Amazon](https://millionrounds.com/fund/amazon) **$60M** Oct 2017

**[Cardioxyl Pharmaceuticals](https://millionrounds.com/company/cardioxyl-pharmaceuticals)** Bought by [Bristol-Myers Squibb](https://millionrounds.com/fund/bristol-myers-squibb) **$2.0B** Nov 2015

**[Receptos](https://millionrounds.com/company/receptos)** Bought by [Celgene](https://millionrounds.com/fund/celgene) **$7.3B** Jul 2015

**[SolarBridge Technologies](https://millionrounds.com/company/solarbridge-technologies)** Bought by SunPower Corporation **Undisclosed** Nov 2014

**[Aerie Pharmaceuticals](https://millionrounds.com/company/aerie-pharmaceuticals)** Listed **Undisclosed** Oct 2013

**[Avid Radiopharmaceuticals](https://millionrounds.com/company/avid-radiopharmaceuticals)** Bought by [Eli Lilly](https://millionrounds.com/fund/eli-lilly) **$800M** Nov 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

New fund on file

**$196M**

raised in Apr 2023

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$40M** the round, not its cheque Alone, median **$5.8M**

Led 0 of 93 rounds **0%**

- **Said size:** $5.0M – $20M
- **Sole investor:** 3 rounds
- **Last cheque:** Aug 2026
- **Exits:** 6 from the portfolio

Rounds by stage said on their site

- Series A said *34*
- Series B said *22*
- Series C *17*
- Series D *7*
- Venture *6*
- Seed said *-*
- Growth said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [OrbiMed](https://millionrounds.com/fund/orbimed) 11
- [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 8
- [Canaan](https://millionrounds.com/fund/canaan-partners) 6
- [Sofinnova Investments](https://millionrounds.com/fund/sofinnova-investments) 6
- [5AM Ventures](https://millionrounds.com/fund/5am-ventures) 5
- [Alta Partners](https://millionrounds.com/fund/alta-partners) 5

**Pitching Osage University Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Osage University Partners. A count of rooms they were both in, not a relationship either has claimed.

[**OrbiMed** Private equity **11** rounds together](https://millionrounds.com/fund/orbimed)[**New Enterprise Associates** VC firm **8** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Canaan** VC firm **6** rounds together](https://millionrounds.com/fund/canaan-partners)[**Sofinnova Investments** VC firm **6** rounds together](https://millionrounds.com/fund/sofinnova-investments)[**5AM Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/5am-ventures)[**Alta Partners** VC firm **5** rounds together](https://millionrounds.com/fund/alta-partners)[**Correlation Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/correlation-ventures)[**General Catalyst** VC firm **5** rounds together](https://millionrounds.com/fund/general-catalyst)[**Hatteras Venture Partners** VC firm **5** rounds together](https://millionrounds.com/fund/hatteras-venture-partners)[**Pfizer** Corporate VC **5** rounds together](https://millionrounds.com/fund/pfizer)[**Sutter Hill Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/sutter-hill-ventures)[**TPG** Private equity **5** rounds together](https://millionrounds.com/fund/tpg)

## Recently backed

The latest companies Osage University Partners put money into.

[**Quintessent** $40M · Aug 2026](https://millionrounds.com/company/quintessent)[**Tessera Labs** $60M · May 2026](https://millionrounds.com/company/tessera-labs)[**Nocion Therapeutics** $23M · Jan 2026](https://millionrounds.com/company/nocion-therapeutics)[**Atsena Therapeutics** $150M · Apr 2025](https://millionrounds.com/company/atsena-therapeutics)[**Vanqua Bio** $85M · Sept 2021](https://millionrounds.com/company/vanqua-bio)[**Artizan Biosciences, Inc.** $11M · Mar 2021](https://millionrounds.com/company/artizan-biosciences-inc)

## Quick answers about Osage University Partners

### What does Osage University Partners invest in?

Osage University Partners invests most often at Series A and Series B (65% of the rounds on record), in sectors such as Graduate, Environnement and Mental Health.

### How active is Osage University Partners?

93 investments on record, 3 of them in the last 12 months. The most recent was in Aug 2026.

### What has Osage University Partners invested in recently?

Its most recent investments on record: Quintessent (Series A, Aug 2026), Tessera Labs (Series A, May 2026) and Nocion Therapeutics (Series B, Jan 2026).

### How big are Osage University Partners's cheques?

The median round it joins is $40M. It says it writes cheques of $5.0M to $20M.

### Does Osage University Partners lead rounds?

Rarely, if at all: none of its 93 investments on record names it as the lead.

### Where does Osage University Partners invest?

Most of the companies it backs are in the United States (97%).

### Is Osage University Partners investing now?

Yes: it is actively investing, with 3 investments in the last 12 months.

### Who does Osage University Partners invest alongside?

Most often OrbiMed (11 rounds together), New Enterprise Associates (8 rounds together) and Canaan (6 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=osage-university-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=osage-university-partners)